Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in Gvhd Risk without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

Blood (2022) 140 (Supplement 1): 282–283.

https://doi.org/10.1182/blood-2022-165782

Published: 2022

Journal Articles

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Beverly J. Lange, Franklin O. Smith, James Feusner, Dorothy R. Barnard, Patricia Dinndorf, Stephen Feig, Nyla A. Heerema, Carola Arndt, Robert J. Arceci, Nita Seibel, Margie Weiman, Kathryn Dusenbery, Kevin Shannon, Sandra Luna-Fineman, Robert B. Gerbing, Todd A. Alonzo

Blood (2008) 111 (3): 1044–1053.

https://doi.org/10.1182/blood-2007-04-084293

Published: 2008

Includes: Supplemental data

Journal Articles

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Marcie Tomblyn, MD, MS, Jeffrey S. Miller, MD, Linda J. Burns, MD, Bruce R. Blazar, MD, PhD, Mukta Arora, MD, MS, Xianghua Luo, PhD, Todd Defor, MS, Claudio Brunstein, MD, PhD, Kathryn Dusenbery, MD, Margaret L. MacMillan, MD, Michael Verneris, MD, PhD, John Wagner, MD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 2999.

https://doi.org/10.1182/blood.V108.11.2999.2999

Published: 2006

Journal Articles

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

Jeffrey S. Miller, MD, Claudio G. Brunstein, MD, Sarah Cooley, MD, Michael R. Verneris, MD, Angela Panoskaltsis-Mortari, MD, Linda J. Burns, MD, David McKenna, MD, Kathryn Dusenbery, MD, Cladd Stevens, MD, Pablo Rubensten, MD, Marcie Tomblyn, MD, Mukta Arora, MD, Margaret L. MacMillan, MD, Todd DeFor, PhD, Chap Le, PhD, Philip B. McGlave, MD, Bruce R. Blazar, MD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 3111.

https://doi.org/10.1182/blood.V108.11.3111.3111

Published: 2006

Journal Articles

Thymic Shielding (TS) in Recipients of Total Body Irradiation (TBI) and Alternative Donor Hematopoietic Stem Cell Transplant (AD-HSCT): Reduced Risk of Opportunistic Infection in Patients with Fanconi Anemia (FA).

Margaret L. MacMillan, MD, Bruce R. Blazar, MD, Todd E. DeFor, MS, Kathryn Dusenbery, MD, John E. Wagner, MD

Blood (2006) 108 (11): 3134.

https://doi.org/10.1182/blood.V108.11.3134.3134

Published: 2006

Journal Articles

Outcomes in CCG-2961, a Children’s Cancer Group Phase III Trial for Untreated Acute Myeloid Leukemia (AML).

Beverly J. Lange, MD, Franklin O. Smith, MD, Patricia A. Dinndorf, MD, Carola A.S. Arndt, MD, Dorothy R. Barnard, MD, Kathryn Dusenbery, MD, Steven A. Feig, MD, James H. Feusner, MD, Sandra Luna-Fineman, MD, Joseph Neglia, MD, MPH, Nita L. Seibel, MD, Leonard Sender, MD, Kevin M. Shannon, MD, Margie Weiman, RN, Robert B. Gerbing, MA, Todd A. Alonzo, PhD

Blood (2005) 106 (11): 169.

https://doi.org/10.1182/blood.V106.11.169.169

Published: 2005

Journal Articles

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group

William G. Woods, Steven Neudorf, Stuart Gold, Jean Sanders, Jonathan D. Buckley, Dorothy R. Barnard, Kathryn Dusenbery, Joetta DeSwarte, Diane C. Arthur, Beverly J. Lange, Nathan L. Kobrinsky

Blood (2001) 97 (1): 56–62.

https://doi.org/10.1182/blood.V97.1.56

Published: 2001

NARROW

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in Gvhd Risk without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

Thymic Shielding (TS) in Recipients of Total Body Irradiation (TBI) and Alternative Donor Hematopoietic Stem Cell Transplant (AD-HSCT): Reduced Risk of Opportunistic Infection in Patients with Fanconi Anemia (FA).

Outcomes in CCG-2961, a Children’s Cancer Group Phase III Trial for Untreated Acute Myeloid Leukemia (AML).

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group

Email alerts

ASH Publications

American Society of Hematology

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in Gvhd Risk without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

Thymic Shielding (TS) in Recipients of Total Body Irradiation (TBI) and Alternative Donor Hematopoietic Stem Cell Transplant (AD-HSCT): Reduced Risk of Opportunistic Infection in Patients with Fanconi Anemia (FA).

Outcomes in CCG-2961, a Children’s Cancer Group Phase III Trial for Untreated Acute Myeloid Leukemia (AML).

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only